Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 194 of 6351
-
Could protecting nighttime sleep in the ICU ward off delirium?
Prevention Recruiting nowDelirium is a common complication in intensive care units (ICUs) and may be associated with sleep disruption and frequent nighttime disturbances. This randomized controlled trial will evaluate whether a multicomponent nighttime sleep-promotion intervention, called the Triple Slee…
Sponsor: Naile ALANKAYA • Aim: Prevention
Last updated Sep 10, 2026 01:00 UTC
-
Could a new Antibody-Lowering drug ease autoimmune brain inflammation?
Disease control Recruiting nowThe POLARIS study is designed to evaluate how well efgartigimod PH20 SC may work (called "efficacy") and how safe it is for people diagnosed with Autoimmune Encephalitis (AIE). The study consists of 4 parts: in part A participants will receive efgartigimod SC; in part B, particip…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can immunotherapy shrink Betel-Nut oral tumors before surgery?
Disease control Not yet recruitingThe goal of this clinical trial is to learn the overall response rate of giving immunothrapy before surgery in treatment-naive, advanced stage patients with Betal-nut-associated oral cavity cancer. The outcomes to be measured by CT scan are overall response rate of either partia…
Phase 2 • Sponsor: Peter Brett, MD • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a targeted drug boost Chemotherapy's power against a rare lymphoma?
Disease control Not yet recruitingThis is a prospective, multicenter, open-label, single-arm, phase II clinical study to evaluate the safety and efficacy of golidocitinib in combination with an anthracycline-based regimen as first-line treatment for patients with previously untreated nodal T-follicular helper (TF…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Eye movement technique may quiet trauma memories without full recall
Disease control Not yet recruitingPost-Traumatic Stress Disorder (PTSD) and trauma-related symptoms are often characterized by recurrent intrusive memories that cause distress and interfere with daily functioning. Although trauma-focused interventions such as Eye Movement Desensitization and Reprocessing (EMDR) m…
Sponsor: Shaanxi Normal University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat esophageal tumors
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability and preliminary antitumor activity of SKB500 combinations in patients with Esophageal Squamous Cell Carcinoma. The study is divided into three parts: the safety run-in phase, randomized enrollment phase and cohort …
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Gut-Targeting drug shield cancer patients from Immunotherapy's worst side effect?
Prevention Recruiting nowThe purpose of this study is to assess the prevention of immune checkpoint inhibitors (ICI) related diarrhea/colitis using vedolizumab in participants with unresectable stage III or metastatic stage IV cancer, starting standard of care (SOC) immunotherapy
Phase 2/3 • Sponsor: AHS Cancer Control Alberta • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Can less radiation be just as effective for tough thyroid cancers?
Disease control Recruiting nowTo explore the efficacy and safety of selective coverage radiotherapy in poorly differentiated and anaplastic thyroid cancer
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
One shot, two viruses? new mRNA vaccine targets RSV and hMPV
Vaccine Recruiting nowThe main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of study interventions across intervention groups
Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Aug 21, 2026 00:00 UTC
-
Simple blood test could spare thousands from unneeded colonoscopies
Diagnosis Recruiting nowColorectal Cancer (CRC), or bowel cancer, is a serious disease that affects many people globally. The earlier CRC is diagnosed, the better the patient outcomes. The problem with the current diagnostic methods is that they lead to many unnecessary endoscopies (colonoscopies). In …
Sponsor: Nordsjaellands Hospital • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
Can some stomach cancer patients skip chemo after surgery?
Disease control Recruiting nowThis study is a randomized, controlled, open-label, multicenter trial. Patients who underwent radical resection for stage IB-IIA gastric or gastroesophageal junction adenocarcinoma were enrolled and stratified into low-risk and high-risk groups based on the presence of lymph node…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could talk therapy and light fix sleep in teens with ADHD?
Symptom relief Not yet recruitingAttention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by persistent inattention, hyperactivity, and impulsivity. In adolescents and young people, ADHD is commonly accompanied by insomnia and circadian delay. These co-occurring sleep and ci…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can matching drugs to tumor genes beat biliary cancer?
Disease control Not yet recruitingThis study is a prospective, multicenter, open-label, umbrella phase II clinical trial. Based on different multigene expression profiling subtypes and potential molecular characteristics of various pathways, 8 treatment arms and 13 treatment groups are preliminarily designed. Aft…
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Two-Drug combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis is a multicenter, prospective, randomized, controlled Phase II trial evaluating the safety and efficacy of MRG003 (Becotatug vedotin) combined with Toripalimab versus Toripalimab alone as neoadjuvant therapy for PD-L1-positive, resectable locally advanced head and neck squam…
Phase 2 • Sponsor: Dongguan People's Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Morning vs. afternoon: could the clock boost immunotherapy against melanoma?
Disease control Recruiting nowThe TIME-NL trial is a multicenter, randomized, open-label clinical trial in the Netherlands to assess the effect of the timing of the first administration of standard-of-care intravenous combination immunotherapy (early morning versus afternoon) in patients with metastatic melan…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Microwave ablation vs. radiotherapy: which Non-Surgical option works best for early lung cancer?
Disease control Not yet recruitingBackground: Stereotactic body radiotherapy (SBRT) is a standard definitive local therapy for medically inoperable early stage non-small cell lung cancer (NSCLC). Navigation bronchoscopy guided microwave ablation is an emerging alternative that may reduce treatment burden and avoi…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a glowing dye reveal hidden bladder cancer during surgery?
Diagnosis Not yet recruitingResearch Objective Taking Trop2, a specific target of bladder urothelial carcinoma, as the research basis, this study adopts a Trop2-targeted near-infrared (NIR) fluorescent probe combined with an intravesical rapid incubation imaging system to investigate the safety of this imag…
Phase 1/2 • Sponsor: Yunnan Cancer Hospital • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Can a new pill quiet the mind? a large trial takes on anxiety
Disease control Recruiting nowThis is a global, phase 3, randomized, double-blind, parallel-group, 2-arm, placebo controlled, multicenter trial designed to compare the efficacy, safety and tolerability of a fixed dose of SEP-363856 (75 millligrams per day \[mg/day\]) to placebo over an 8-week double-blind tre…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can targeted brain zaps ease movement problems in a rare ataxia?
Disease control Not yet recruitingThe purpose of this research study is to identify the optimal biological dose for tTIS that targets DN in SCA3 while achieving the best possible balance between therapeutic efficacy and safety.
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a Needle-Free prostate treatment match implant surgery?
Disease control Recruiting nowThis clinical trial aims to determine whether Prolieve® (microwave with balloon dilation) is as effective as UroLift® (prostate implants) for treating moderate-to-severe lower urinary tract symptoms in men aged 50-80 with enlarged prostates (BPH) who have failed oral medications.…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC